封面
市場調查報告書
商品編碼
1363220

心臟衰竭POC和LOC設備市場規模、佔有率和趨勢分析報告:按測試類型、技術、最終用途、地區和細分市場趨勢:2023-2030年

Heart Failure POC And LOC Devices Market Size, Share & Trends Analysis Report By Test Type, By Technology, By End Use, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 122 Pages | 商品交期: 2-10個工作天內

價格

心臟衰竭POC和LOC設備市場成長和趨勢:

根據 Grand View Research, Inc. 的最新報告,預計到2030年,全球心臟衰竭POC和LOC設備市場規模將達到 2.849 億美元,2023年至2030年年複合成長率為 16.9%。

該市場是由診斷領域的範式轉變所推動的,從階段疾病檢測到疾病的早期識別,作為抑制不斷上漲的醫療成本的可行策略。這一轉變導致了拋棄式、低成本 LOC 設備的開發,該設備將各種感測器和相關配件整合到一個空間中,以檢測一個檢體中的心臟生物標記物,評估心臟病發作的風險。

此外,基於預測建模技術的決策支援軟體的開發是市場促進因素之一,該軟體檢測LOC 測定測量的資料以實現治療監測。此外,進行的應用基於唾液的奈米生物晶片測試來檢測心肌梗塞的研究推動有機收益成長。

POC 測試代表了各種環境下的潛在節省,包括醫院、全科診所和偏遠地區。在美國,POC 設備已將胸痛病房的住院人數減少了20%,節省了大量時間和成本。

在心臟觀察單位(美國),實施 POC 肌鈣蛋白檢測可縮短住院時間、降低入院率、消除昂貴的多次手術的需要,並將每位患者的成本降低 25%。此外,將智慧型手機和應用程式整合到 POC 診斷中以管理個人心臟健康是心臟衰竭POC和LOC設備市場的關鍵創新之一。

心臟衰竭POC和LOC設備市場報告亮點

  • 蛋白質體分析包括測試蛋白質標記物的產品,例如肌鈣蛋白、肌紅蛋白和肌酸激酶 MB同功異構酵素(CK-MB)。
  • 由於目前大多數可用產品都是基於蛋白質標記測試,因此該細分市場佔據了主要收益佔有率。
  • 擴大採用微流控 LOC 技術來評估假定的生物標記物,導致該技術的收益佔有率最大。
  • 微流控技術已被引進各種生物應用中,包括免疫雜交技術、酵素測定和 PCR。
  • 醫療辦公室,包括醫生辦公室、藥房/零售診所、緊急護理診所和非診所診所,是主要的收益最終用戶。
  • 全科醫生大量使用 POC 設備來進行快速調查、早期治療決策、及時轉診和減少患者的不確定性,這是該診所收益成長的驅動力。
  • 美國在全球心臟衰竭POC和LOC設備市場中佔據主導地位,因為大量初級保健診所已實施 POC 心臟標記檢測作為心臟衰竭早期檢測的手段。
  • 不斷發展的都市化和不斷增加的老年人口支持對強大和改進的醫療保健服務的需求,例如亞洲國家用於常規心臟健康監測的 POC 診斷。
  • 此外,也對年輕負責人進行 POC 心肌肌鈣蛋白 T/心肌肌鈣蛋白 I 生物標記的培訓配合措施。
  • 因此,亞洲國家 POC 設備的採用率預計將飆升。
  • Abbott、Siemens Healthineers、Danahar和F. Hoffmann-La Roche是該領域的主要企業。
  • 每家公司都在併購新興企業。 Abbott收購Alere、Danahar收購Beckman Coulter, Inc. 以及 Instrumentation Laboratory收購Accriva Diagnostics 都是該市場收購的例子。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 心臟衰竭POC和LOC設備市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 心臟衰竭POC和LOC設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 心臟衰竭POC和LOC設備:按測試類型進行估計和趨勢分析

  • 心臟衰竭POC和LOC設備市場:重點
  • 心臟衰竭POC和LOC設備市場:2022年和2030年趨勢和市場佔有率分析
  • 蛋白質體學測試
  • 代謝組測試
  • 基因組測試

第5章 心臟衰竭POC和LOC設備:技術估計和趨勢分析

  • 心臟衰竭POC和LOC設備市場:重點
  • 心臟衰竭POC和LOC設備市場:2022年和2030年趨勢和市場佔有率分析
  • 微流體學
  • 基於陣列的系統
  • 其他

第6章 心臟衰竭POC和LOC設備:最終用途的估計和趨勢分析

  • 心臟衰竭POC和LOC設備市場:重點
  • 心臟衰竭POC和LOC設備市場:2022年和2030年趨勢和市場佔有率分析
  • 診所
  • 醫院
  • 家庭
  • 輔助醫療設施
  • 實驗室

第7章 心臟衰竭POC和LOC設備市場:區域估計和趨勢分析

  • 區域展望
  • 依地區分類的心臟衰竭POC和LOC設備市場:要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東、非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott Laboratories
    • Siemens Healthineers
    • Danaher
    • Instrumentation Laboratory
    • F. Hoffmann-La Roche Ltd.
    • bioMerieux SA
    • Abaxis, Inc.
    • Quidel Corporation
    • Jant Pharmacal Corporation
    • Trinity Biotech
Product Code: GVR-3-68038-980-7

Heart Failure POC And LOC Devices Market Growth & Trends:

The global heart failure POC and LOC devices market size is expected to reach USD 284.9 million by 2030 and is projected to grow at a CAGR of 16.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. A paradigm shift in diagnostic sectors from late-stage disease detection to early identification of diseases as a viable strategy to curb rising healthcare costs has driven the market. This shift has led to the development of disposable and low-cost LOC devices that integrate various sensors and associated accessories in a single space for detection of the cardiac biomarkers from a single specimen to evaluate the risk of having a heart attack.

Furthermore, the development of predictive modeling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on the application of saliva-based nano-biochip tests for measuring myocardial infarction is driving organic revenue growth.

POC testing exhibits potential savings across various settings, including hospitals, general practice, and remote areas. In the U.S., the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.

In the cardiac observation unit (U.S.), the implementation of POC troponin testing helped reduce hospital stays, decrease admission rates, and remove the need for multiple costly procedures, resulting in 25% cost saving per patient. Furthermore, the integration of smartphones and apps in POC diagnostics for managing the cardiac health of an individual is one of the significant innovations in Heart Failure POC & LOC Devices market.

Heart Failure POC And LOC Devices Market Report Highlights:

  • Proteomic analysis includes products that test protein markers, such as troponin, myoglobin, and Creatine Kinase MB Isoenzyme (CK-MB)
  • This segment accounted for the leading revenue share, as most of the currently available products are based on testing of protein markers
  • Increasing implementation of microfluidic LOC technology for assessing putative biomarkers has led to the largest revenue share of this technology
  • Microfluidic technologyhas been implemented for various biological applications, such as immunohybridization techniques, enzymatic assays, PCR, and others
  • Clinics that include physician's office, pharmacy & retail clinics, urgent care clinics, and non-practice clinics are the key revenue generating end-users
  • A high usage rate of POC devices by general practitioners for rapid investigation, deciding early treatment, timely referral, and less uncertainty for patients has driven the revenue growth through clinics
  • The U.S. dominated the global Heart Failure POC & LOC devices market owing to the presence of a substantial number of primary care clinics that are deploying POC cardiac marker test as a measure for early detection of heart failure
  • Expanding urbanization and increasing geriatric population underpin the demand for robust and improved healthcare services such as POC diagnostics for routine cardiac health monitoring in Asian countries
  • Moreover, initiatives are undertaken for training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers
  • This, in turn, is anticipated to result in the surging adoption rate of POC devices in Asian countries
  • Abbott, Siemens Healthineers, Danahar, and F. Hoffmann-La Roche Ltd are some key participants operating in the space
  • Companies are engaged in mergers and acquisitions of emerging players. Acquisition of Alere by Abbott, Beckman Coulter, Inc by Danahar, and Accriva Diagnostics by Instrumentation Laboratory are some examples of acquisitions in this market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test type
    • 1.1.2. Technology
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Heart Failure POC & LOC Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Heart Failure POC & LOC Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Heart Failure POC & LOC Devices: Test Type Estimates & Trend Analysis

  • 4.1. Heart Failure POC & LOC Devices Market: Key Takeaways
  • 4.2. Heart Failure POC & LOC Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Proteomic Testing
    • 4.3.1. Proteomic testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Metabolomic Testing
    • 4.4.1. Metabolomic testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Genomic Testing
    • 4.5.1. Genomic testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Heart Failure POC & LOC Devices: Technology Estimates & Trend Analysis

  • 5.1. Heart Failure POC & LOC Devices Market: Key Takeaways
  • 5.2. Heart Failure POC & LOC Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Microfluidics
    • 5.3.1. Microfluidics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Array-based Systems
    • 5.4.1. Array-based systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Heart Failure POC & LOC Devices: End Use Estimates & Trend Analysis

  • 6.1. Heart Failure POC & LOC Devices Market: Key Takeaways
  • 6.2. Heart Failure POC & LOC Devices Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Clinics
    • 6.3.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Home
    • 6.5.1. Home market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Assisted Living Healthcare Facilities
    • 6.6.1. Assisted living healthcare facilities market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Laboratory
    • 6.7.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Heart Failure POC & LOC Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Heart Failure POC & LOC Devices Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott Laboratories
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Siemens Healthineers
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Danaher
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Instrumentation Laboratory
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. F. Hoffmann-La Roche Ltd.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. bioMerieux S.A.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Abaxis, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Quidel Corporation
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Jant Pharmacal Corporation
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiative
    • 8.2.10. Trinity Biotech
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 7 U.S. heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Canada heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Europe heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Germany heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 20 UK heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 23 France heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Italy heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Spain heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Denmark heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 35 Sweden heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Norway heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 45 Japan heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Japan heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 48 China heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 49 China heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 51 India heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Australia heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Australia heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 57 Thailand heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Thailand heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 60 South Korea heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 63 Latin America heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Latin America heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Brazil heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Mexico heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 73 Argentina heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 80 South Africa heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 86 UAE heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Heart failure POC & LOC devices: Market outlook
  • Fig. 9 Heart failure POC & LOC devices: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Heart failure POC & LOC devices market driver impact
  • Fig. 15 Heart failure POC & LOC devices market restraint impact
  • Fig. 16 Heart failure POC & LOC devices market strategic initiatives analysis
  • Fig. 17 Heart failure POC & LOC devices market: Test type movement analysis
  • Fig. 18 Heart failure POC & LOC devices market: Test type outlook and key takeaways
  • Fig. 19 Solid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Proteomic testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Metabolomic testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Genomic testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Heart failure POC & LOC devices market: Technology movement analysis
  • Fig. 24 Heart failure POC & LOC devices market: Technology outlook and key takeaways
  • Fig. 25 Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Array-based systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Heart failure POC & LOC devices market: End use movement analysis
  • Fig. 29 Heart failure POC & LOC devices market: End use outlook and key takeaways
  • Fig. 30 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Home market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Assisted living healthcare facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Laboratory market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Global heart failure POC & LOC devices market: Regional movement analysis
  • Fig. 36 Global heart failure POC & LOC devices market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)